sellModerate cluster of 410b5-1 plan
BENKOWITZ MICHAEL sold $3.7M of UTHR
PRESIDENT AND COO at UNITED THERAPEUTICS Corp. 10,000 shares at an average of $370.14, traded Dec 16, 2024, filed Dec 17, 2024.
Warning score
45Value
$3.7M
10,000 shares
Holdings after
0
-133% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001562180-24-008451, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 16, 2024 | MOption exercise Common Stockindirect: By Trust10b5-1 | +3,352 | $111.00 | $372k | 3,352 | Dec 17, 2024 |
| Dec 16, 2024 | MOption exercise Common Stockindirect: By Trust10b5-1 | +4,148 | $111.00 | $460k | 7,500 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -100 | $363.25 | $36k | 7,400 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -100 | $364.97 | $36k | 7,300 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -768 | $367.70 | $282k | 6,532 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,336 | $368.94 | $493k | 5,196 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,510 | $369.90 | $559k | 3,686 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,981 | $370.96 | $735k | 1,705 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,644 | $372.18 | $612k | 61 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -61 | $372.60 | $23k | 0 | Dec 17, 2024 |
| Dec 16, 2024 | MOption exercise Common Stockindirect: By Trust10b5-1 | +2,500 | $111.00 | $278k | 2,500 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -100 | $363.25 | $36k | 2,400 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -300 | $368.16 | $110k | 2,100 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -800 | $369.57 | $296k | 1,300 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -800 | $370.93 | $297k | 500 | Dec 17, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -500 | $372.15 | $186k | 0 | Dec 17, 2024 |
| Dec 16, 2024 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -3,352 | $0.00 | $0 | 82,179 | Dec 17, 2024 |
| Dec 16, 2024 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -4,148 | $0.00 | $0 | 0 | Dec 17, 2024 |
| Dec 16, 2024 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -2,500 | $0.00 | $0 | 29,500 | Dec 17, 2024 |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 25Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $640k | 2,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.0M | 9,679 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.5M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.5M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.